Denecke, Agnieszka http://orcid.org/0000-0003-1648-4452
Iftner, Thomas
Iftner, Angelika
Riedle, Sebastian
Ocak, Marion
Luyten, Alexander
Üye, Isak
Tunc, Kübra
Petry, Karl Ulrich
Funding for this research was provided by:
Merck Sharp and Dohme
Hologic
Article History
Received: 1 October 2019
Accepted: 5 May 2021
First Online: 2 July 2021
Declarations
:
: The ethics committee of Lower Saxony in Hannover approved WOLVES as an epidemiological non-interventional study (Nr Bo/07/2009). All participants gave written informed consent.
: Not applicable.
: KUP received an honorarium from Merck-MSD for participation in an advisory board. TI has patents for “Primer and probes for detection of papillomaviruses” DE 103 57 677 A1 (Co-Inventor, T. Iftner; ownership, Greiner Bio-One GmbH) and “Detection of human papillomaviruses” European patent and EP Swiss EPÜ 1272675 (Inventor, T. Iftner; ownership, Eberhard-Karls-Universitaet Tuebingen, Germany), has received speaker honoraria from Hologic, BD Diagnostics, and MSD, and has received unconditional research grants to the University Hospital of Tuebingen from Hologic, USA (IIT) and Becton-Dickinson, Germany (IIT). The other authors declare that they have no competing interests.